Nubeqa: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

24 November 2024

  • curprev 17:0317:03, 24 November 2024‎ Omid Afkhami-Ardakani talk contribs‎ 4,366 bytes +4,366‎ Created page with "{{DrugProjectFormSinglePage |authorTag=Omid Afkhami Ardakani |genericName=Darolutamide |aOrAn=a |drugClass=Nonsteroidal Antiandrogen (NSAA) |indicationType=treatment |indication=Non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) in adult men. It can also be used for treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in combination with docetaxel in adult men. |adverseReactions=Fatigue, Pain in extremities, Rash, Decreased neutrophil count, and I..."
Retrieved from "https://www.wikidoc.org/index.php/Nubeqa"